...
首页> 外文期刊>Journal of molecular graphics & modelling >Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists
【24h】

Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists

机译:过氧化物酶体增殖物激活受体γ的多构象动态药效团模型,用于发现新型激动剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Activation of the peroxisome proliferator-activated receptor γ (PPARγ) is important for the treatment of type 2 diabetes and obesity through the regulation of glucose metabolism and fatty acid accumulation. Hence, the discovery of novel PPARγ agonists is necessary to overcome these diseases. In this study, a newly developed approach, multi-conformation dynamic pharmacophore modeling (MCDPM), was used for screening candidate compounds that can properly bind PPARγ. Highly populated structures obtained from molecular dynamics (MD) simulations were selected by clustering analysis. Based on these structures, pharmacophore models were generated from the ligand-binding pocket and then validated to check the rationality. Consequently, two hits were retrieved as final candidates by utilizing virtual screening and molecular docking simulations. These compounds can be used in the design of novel PPARγ agonists.
机译:过氧化物酶体增殖物激活受体γ(PPARγ)的激活通过调节葡萄糖代谢和脂肪酸积累,对于治疗2型糖尿病和肥胖症很重要。因此,发现新的PPARγ激动剂对于克服这些疾病是必要的。在这项研究中,一种新开发的方法,多构象动态药效团建模(MCDPM),用于筛选可以正确结合PPARγ的候选化合物。通过聚类分析选择了从分子动力学(MD)模拟获得的高密度结构。基于这些结构,从配体结合袋中生成药效团模型,然后对其进行验证以验证其合理性。因此,通过利用虚拟筛选和分子对接模拟,检索到两个命中点作为最终候选者。这些化合物可用于新型PPARγ激动剂的设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号